Coagulation Testing Quality
Conference and Wet Workshop

 

Coagulation Wet Workshop Faculty

Tuesday, August 7, 2012

Mayo Clinic Faculty

Layna K. Cardel, BS, MT (ASCP)*
Coagulation Educational Specialist and Coordinator
Mayo Special Coagulation Laboratory
Hematopathology Division, Department of Laboratory Medicine & Pathology
Instructor, Laboratory Medicine†

John A. Heit, MD
Consultant, Cardiovascular Medicine, Hematology and Coagulation
Co-Director, Mayo Special Coagulation DNA Diagnostic Laboratory
Professor, Medicine†

Elizabeth M. Kock, MT (ASCP)
Coagulation Educational Specialist
Mayo Special Coagulation Laboratory
Hematopathology Division, Department of Laboratory Medicine & Pathology†

William L. Nichols, MD**
Consultant, Laboratory Medicine and Hematology/Internal Medicine
Mayo Special Coagulation Laboratories and Coagulation Clinical Centers
Associate Professor, Medicine and Laboratory Medicine†

Rajiv K. Pruthi, MBBS**
Consultant, Hematology/Internal Medicine and Laboratory Medicine
Mayo Special Coagulation Laboratories and Coagulation Clinical Centers
Co-Director, Mayo Special Coagulation Laboratory and DNA Diagnostic Laboratory
Co-Director, Coagulation Clinical and Laboratory Practice
Director, Mayo Comprehensive Hemophilia Center
Associate Professor, Medicine†

*Wet Workshop Coordinator
**Wet Workshop Co-Directors
†College of Medicine, Mayo Clinic, Rochester, Minnesota

Guest Faculty

Dorothy M. (Adcock) Funk, MD
Medical and Laboratory Director, Coagulation
Esoterix, Inc.
Englewood, Colorado

Jana N. Gausman, MT (ASCP)
Supervisor of Hematology and Coagulation Laboratories
Pathology and Laboratory Medicine Services
Oklahoma City Veterans Adminstration Medical Center
Oklahoma City, Oklahoma

John D. Olson, MD, PhD
Director of Clinical Laboratories
Professor of Pathology and Vice Chair for Clinical Affairs
Department of Pathology
University of Texas Health Science Center
San Antonio, Texas

Faculty Disclosure

As a provider accredited by ACCME, College of Medicine, Mayo Clinic (Mayo School of Continuous Professional Development) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.